Compare EOG Resources Inc (EOG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs Zimmer Biomet Holdings Inc — how do they compare? EOG Resources Inc trades at $138.59 (market cap $73.22B), while Zimmer Biomet Holdings Inc trades at $93.09 (market cap $17.44B). The key difference: EOG Resources Inc is far larger — about 4.2× Zimmer Biomet Holdings Inc's market cap, and EOG Resources Inc pays the higher dividend (2.97%). Which is the better fit depends on your goals.
| EOG | ZBH | |
|---|---|---|
Market Cap | $73.22B | $17.44B |
Sector | Energy | Health |
52-Week High | $149.89 | $107.71 |
52-Week Low | $101.78 | $79.58 |
Enterprise Value | $77.68B | $24.49B |
Dividend Yield | 2.97% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $139.12, up 0.8% on the day, with a bullish technical outlook supported by moving averages and key resistance at $140. The company maintains strong profitability with a 23.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights EOG's valuation discount and operational strength, with a consensus price target of $156.40 suggesting 12% upside.
EOG presents a compelling investment case with solid fundamentals, consistent earnings beats, and positive analyst sentiment, though risks include oil price volatility and elevated capital expenditures. The stock's current valuation below historical averages offers a margin of safety for long-term investors seeking exposure to a high-quality energy producer.
Zimmer Biomet (ZBH) trades at $92.94, up 2.1% on the day, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a 70% gross margin and positive cash flow trends, though net income margin has declined from 13.8% in 2023 to 8.6% in 2025. Recent developments include expansion in Asia Pacific and a planned $1 billion share repurchase, indicating management confidence.
ZBH presents a moderate growth opportunity with a consensus price target of $97.67, offering ~5% upside. Risks include rising debt levels and competitive pressures in medical devices. Analyst sentiment is mixed with 40% buy ratings, but institutional activity and strategic acquisitions support a stable outlook for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
